Structural biology opens new perspectives for treating psychiatric disorders

(European Molecular Biology Laboratory) Employing innovative technologies for combining data from hundreds of crystals, scientists determined the molecular structure of Glycine Transporter 1, a protein that modulates neuronal activity in the brain. The revealed binding sites through which the transporter can be inhibited by drugs. This could open new avenues for developing psychiatric drugs. The study was conducted by researchers at the European Molecular Biology Laboratory (EMBL) Hamburg, Aarhus University, F. Hoffmann-La Roche, Linkster Therapeutics, and University of Zurich.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news